CN Patent

CN101412742B — 一种抑制血管新生的硝酸酯药物

Assigned to Tianjin Jinyao Group Co Ltd · Expires 2013-07-31 · 13y expired

What this patent protects

一种抑制血管新生的硝酸酯药物，为如下通式的化合物1或其酯或盐：T-(B-O-NO2) t1 ，t1为1或2，T-H为甾体化合物，T为化合物1除去H的甾体残基，T与H是以T上的氧原子与H相连，形成羟基即O-H的形式相连，该化合物用于制备治疗肿瘤、眼部血管新生性疾病的药物。

USPTO Abstract

一种抑制血管新生的硝酸酯药物，为如下通式的化合物1或其酯或盐：T-(B-O-NO2) t1 ，t1为1或2，T-H为甾体化合物，T为化合物1除去H的甾体残基，T与H是以T上的氧原子与H相连，形成羟基即O-H的形式相连，该化合物用于制备治疗肿瘤、眼部血管新生性疾病的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101412742B
Jurisdiction
CN
Classification
—
Expires
2013-07-31
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Jinyao Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.